Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
May 25, 2022

EMA grants orphan drug designation to Cornerstone Pharmaceuticals’ CPI-613 (devimistat)

Cornerstone Pharmaceuticals has announced that the European Medicines Agency (EMA) has granted orphan drug designation (ODD) to CPI-613 (devimistat) to treat advanced unresectable biliary tract cancer.

Continue
Image: Biliary tract cancer, which is also called as cholangiocarcinoma, is an extremely rare and hard to treat cancer. Credit: Nephron/commons.wikimedia.org.
May 24, 2022

FDA accepts review of Biohaven’s NDA for zavegepant nasal spray

Image: Zavegepant nasal spray is intended for acute treatment of migraine in adults. Credit: Gerd Altmann from Pixabay.
May 23, 2022

Novartis’ Cosentyx gets CHMP positive opinion for use in childhood arthritic conditions

Image: ERA and JPsA are progressive and debilitating autoimmune diseases. Credit: Rudy and Peter Skitterians from Pixabay.

Contracts

May 3, 2022

Intravac signs licensing deal with Zhifei Lvzhu for whooping cough vaccine

Image: There are more than 24 million cases of whooping cough every year across the world. Credit: owfiqu barbhuiya on Unsplash.

Ardelyx amends license deal with Kyowa Kirin for tenapanor

Clovis Oncology, Evergreen partner for actinium-225-labeled FAP-2286

Altamira, Nuance Pharma sign distribution deal for Bentrio in Asian markets

Deals

Deals May 20, 2022

Inceptor Bio raises $37m from Series A to advance CAR-T lead programme

Pharmaceutical Business Review

SwanBio raises $56m to advance new gene therapies for neurological conditions

Procaps Group signs agreement to buy Grupo Somar

Proteros expands oncology collaboration with AstraZeneca

Popular

  1. Statera Biopharma, Lay Sciences announce intent to enter strategic partnership
  2. Stealth receives FDA orphan drug designation for elamipretide to treat DMD
  3. Artax Biopharma to develop oral small molecule immunomodulating agent
  4. Moma Therapeutics completes funding for precision oncology programmes
  5. GNS and Arvinas partner for neurodegenerative disease drug development

PRESS RELEASES

Gerresheimer Traceability Solution: Full Transparency Right from the Beginning
Gerresheimer Traceability Solution: Full Transparency Right from the Beginning
Pharmaceutical Business Review
Tosoh Bioscience Introduces TSKgel® UP-SW3000-LS UHPLC Columns
Promega Spring Art Showcase Presents Light and Color Featuring Three Wisconsin Artists
Promega Spring Art Showcase Presents Light and Color Featuring Three Wisconsin Artists
Expert Corner: Reframing Human Error for Team Success – June 7
Expert Corner: Reframing Human Error for Team Success – June 7
NSF at Interphex 2022 in New York, 24 May
NSF at Interphex 2022 in New York, 24 May

Suppliers

Whitepapers

Deeper Insight into the Pyrolysis of Acetylsalicylic Acid by Means of Kinetic Analysis
Deeper Insight into the Pyrolysis of Acetylsalicylic Acid by Means of Kinetic Analysis
Affinity Tag Coating Enables Reliable Detection of Antigen-Specific B Cells in Immunospot Assays
Affinity Tag Coating Enables Reliable Detection of Antigen-Specific B Cells in Immunospot Assays
Deuterium-Containing Building Blocks for Drug Design
Deuterium-Containing Building Blocks for Drug Design